Table 3 Comparisons of surgical outcomes and postoperative clinical characteristics between two groups.

From: RIRS with flexible vacuum-assisted ureteral access sheath for large renal stones: a prospective randomized controlled study

Variables, mean ± SD or n (%)

FV-UAS group (n = 75)

MPCNL group (n = 74)

t/χ2 value

P value

Immediately SFR

59 (78.7)

60 (81.1)

0.135

0.713

Total SFR

67 (89.3)

65 (87.8)

0.082

0.774

Lithotripsy time, min

113.1 ± 6.7

82.5 ± 5.4

30.670

< 0.001**

Hemoglobin decrease, g/L

8.2 ± 3.3

17.7 ± 2.9

− 18.656

< 0.001**

Postoperative hospital stays, days

1.7 ± 0.6

3.1 ± 0.5

− 15.462

< 0.001**

Balloon dilatation

8 (10.7)

Required second access tracts

23 (31.1)

Qol score improvement

33.4 ± 6.5

26.9 ± 7.1

5.830

< 0.001**

3 months ureteral stricture

1 (1.3)

3 (4.1)

1.055

0.304

Clavien-Dindo

  

5.655

0.017*

 Grade Ⅰ-Ⅱ

7 (9.3)

16 (21.6)

 Grade Ⅲ-Ⅳ

1 (1.3)

3 (4.1)

Complications

 Fever (> 38.5℃) (Clavien grade Ⅰ)

5 (6.7)

9 (12.2)

1.337

0.247

 Low back pain (Clavien grade Ⅰ)

4 (5.2)

13 (17.6)

5.516

0.019*

 Perirenal hematoma (Clavien grade Ⅱ)

2 (2.6)

11 (14.9)

6.959

0.008**

 Blood transfusion (Clavien grade Ⅱ)

0 (0.0)

2 (2.7)

2.055

0.152

 Urosepsis (Clavien grade Ⅳ)

1 (1.3)

3 (4.1)

1.055

0.304

Stone compositions

  

2.096

0.553

 Calcium oxalate

44 (60.0)

42 (54.3)

 Calcium phosphate

13 (6.3)

8 (6.4)

 Struvite or carbonated apatite

11 (24.2)

15 (27.6)

 Uric acid or cysteine

7 (9.5)

9 (11.7)

  1. SD = standard deviation; SFR = stone-free rate; QoL = Quality of life;
  2. * P < 0.05, **P < 0.01.;